Enfusion (NYSE:ENFN) Sets New 1-Year High – Should You Buy?

Enfusion, Inc. (NYSE:ENFN) hit a new 52-week high on Monday . The company traded as high as $10.41 and last traded at $10.35, with a volume of 166401 shares traded. The stock had previously closed at $10.21.

Enfusion Price Performance

The business has a 50-day moving average of $9.38 and a two-hundred day moving average of $8.91. The company has a market cap of $1.33 billion, a P/E ratio of 255.31, a P/E/G ratio of 3.82 and a beta of 0.97.

Insider Transactions at Enfusion

In related news, COO Neal Pawar sold 21,801 shares of the firm’s stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $10.03, for a total value of $218,664.03. Following the completion of the transaction, the chief operating officer now owns 1,143,544 shares in the company, valued at $11,469,746.32. This trade represents a 1.87 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 36.44% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the company. TenCore Partners LP purchased a new position in Enfusion during the third quarter valued at approximately $3,938,000. Dimensional Fund Advisors LP increased its holdings in shares of Enfusion by 57.5% during the 2nd quarter. Dimensional Fund Advisors LP now owns 524,142 shares of the company’s stock valued at $4,466,000 after purchasing an additional 191,436 shares in the last quarter. Impax Asset Management Group plc lifted its stake in shares of Enfusion by 25.4% in the 3rd quarter. Impax Asset Management Group plc now owns 676,948 shares of the company’s stock valued at $6,424,000 after purchasing an additional 136,948 shares during the period. Scalar Gauge Management LLC grew its position in Enfusion by 21.8% during the second quarter. Scalar Gauge Management LLC now owns 613,513 shares of the company’s stock valued at $5,227,000 after buying an additional 110,000 shares during the period. Finally, SG Americas Securities LLC purchased a new position in Enfusion in the third quarter valued at $892,000. 81.05% of the stock is currently owned by hedge funds and other institutional investors.

About Enfusion

Enfusion, Inc provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.